Home
ยป
Pionyr Immunotherapeutics
Skip to content
FinSMEs
REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS
Search for:
Facebook
Twitter
Linkedin
Navigation
Site navigation
USA
UK
Germany
France
Canada
India
Italy
Home
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics
USA
Gilead Sciences To Acquire 49.9 % Equity In Pionyr Immunotherapeutics, For $275M
USA
Pionyr Immunotherapeutics Completes $62M in Series B Financing
Sign-up now to the Daily Newsletter